Clinical Trial

A Phase II Clinical Trial of Efficacy and Safety of SAL0140 at Different Doses in Patients With Chronic Kidney Disease

Name: A Phase II Clinical Trial of Efficacy and Safety of SAL0140 at Different Doses in Patients With Chronic Kidney Disease — clinical trial record (NCT07647133)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This study will evaluate the efficacy and safety of SAL0140 in patients with chronic kidney disease (CKD).

Trial Details

NCT Number	NCT07647133
Lead Sponsor	Shenzhen Salubris Pharmaceuticals Co., Ltd.
Conditions	Chronic Kidney Disease
Enrollment	249 participants
Start Date	2026-06-15
Primary Completion	2027-10-08 (estimated)
Study Completion	2027-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-06-15